<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Algorithm for increasing oral aspirin dose from 81 mg to 325 mg in an adult patient with NSAID hypersensitivity</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Algorithm for increasing oral aspirin dose from 81 mg to 325 mg in an adult patient with NSAID hypersensitivity</h1>
<div class="graphic"><div class="figure"><div class="ttl">Algorithm for increasing oral aspirin dose from 81 mg to 325 mg in an adult patient with NSAID hypersensitivity</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">For important information on the safe use of these protocols (eg, appropriate settings, indications, and contraindications), refer to the UpToDate topic on introduction of aspirin to patients with aspirin hypersensitivity requiring cardiovascular interventions.</div><div class="graphic_footnotes"><p>NSAID: nonsteroidal antiinflammatory drug.</p>
<p>* 81 mg is the common dose for low-dose aspirin in the United States. In many other countries, 100 mg is the common low dose.</p>
<p>¶ If patient was not premedicated for aspirin introduction in the previous 24 hours, then give montelukast 10 mg at least 1 hour before beginning the procedure. If asthma is not well controlled, give prednisone 40 mg orally at least 2 hours before.</p>
Δ Symptoms should be treated if they occur:
<ul>
<li>Albuterol for wheezing, chest tightness, or cough</li>
<li>Oxymetazoline or other nasal decongestant spray for nasal obstruction</li>
</ul>
<p class="extra_spacing">If severe symptoms occur at a certain dose, that dose should be repeated, and the protocol should be continued after 60 minutes of observation. Patients usually do not react again to the same dose when it is repeated.</p>
◊ If symptoms develop, give:
<ul>
<li>Montelukast 10 mg</li>
<li>Cetirizine 10 mg orally or diphenhydramine 50 mg intravenously or orally, and</li>
<li>Prednisone 40 mg orally or methylprednisolone 40 mg intravenously</li>
</ul>
<p class="extra_spacing_top">Then, continue the protocol without repeating steps.</p></div><div class="graphic_reference">Courtesy of Ronald A Simon, MD.</div><div id="graphicVersion">Graphic 112849 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
